According to Pharma Mar's latest financial reports the company's current revenue (TTM) is $0.17 B. In 2022 the company made a revenue of $0.20 B a decrease over the years 2021 revenue that were of $0.26 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $0.17 B | -17.44% |
2022 | $0.20 B | -21.94% |
2021 | $0.26 B | -13.85% |
2020 | $0.30 B | 222.05% |
2019 | $95.98 M | -43.77% |
2018 | $0.17 B | -16.95% |
2017 | $0.20 B | 2.68% |
2016 | $0.20 B | -10.94% |
2015 | $0.22 B | 15.36% |
2014 | $0.19 B | 4.48% |
2013 | $0.18 B | -18.2% |
2012 | $0.22 B | -13.06% |
2011 | $0.26 B | 30.26% |
2010 | $0.20 B | 15.4% |
2009 | $0.17 B | 11.04% |
2008 | $0.15 B |